These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies. Hirata Y, Yokote T, Kobayashi K, Nakayama S, Oka S, Miyoshi T, Akioka T, Hiraoka N, Iwaki K, Takayama A, Nishimura Y, Makino J, Takubo T, Tsuji M, Hanafusa T. Leuk Lymphoma; 2010 May; 51(5):853-9. PubMed ID: 20214445 [Abstract] [Full Text] [Related]
29. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis. Fortún J, Muriel A, Martín-Dávila P, Montejo M, Len O, Torre-Cisneros J, Carratalá J, Muñoz P, Fariñas C, Moreno A, Fresco G, Goikoetxea J, Gavaldá J, Pozo JC, Bodro M, Vena A, Casafont F, Cervera C, Silva JT, Aguado JM, Grupo de Estudio de Infección en Pacientes Trasplantados-Grupo de Estudio de Micología Médica (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica), and Red Española de Investigación en Patología Infecciosa. Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146 [Abstract] [Full Text] [Related]
30. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species. Cornely OA, Vazquez J, De Waele J, Betts R, Rotstein C, Nucci M, Pappas PG, Ullmann AJ. Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573 [Abstract] [Full Text] [Related]
31. Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT. Park HJ, Park M, Han M, Nam BH, Koh KN, Im HJ, Lee JW, Chung NG, Cho B, Kim HK, Yoo KH, Koo HH, Kang HJ, Shin HY, Ahn HS, Lim YT, Kook H, Lyu CJ, Hah JO, Park JE, Lim YJ, Seo JJ. Bone Marrow Transplant; 2014 Sep; 49(9):1212-6. PubMed ID: 25000455 [Abstract] [Full Text] [Related]
32. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. Winston DJ, Limaye AP, Pelletier S, Safdar N, Morris MI, Meneses K, Busuttil RW, Singh N. Am J Transplant; 2014 Dec; 14(12):2758-64. PubMed ID: 25376267 [Abstract] [Full Text] [Related]
37. Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials. Lee CH, Lin JC, Ho CL, Sun M, Yen WT, Lin C. PLoS One; 2017 Jun; 12(7):e0180050. PubMed ID: 28700646 [Abstract] [Full Text] [Related]
39. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin. Doria C, Bodzin AS, Vaccino S, Daskalakis C, Krawitz S, Ramirez CB. Clin Transplant; 2011 Jun; 25(4):569-75. PubMed ID: 20662881 [Abstract] [Full Text] [Related]